Asbestos related disease

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Analysing Medical Investigations
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Asbestos Related Lung Disease     

Title               

Ñ    Asbestos Related Lung Disease

Definition

Ñ    Lung disease related to asbestos exposure

Aetiology

Types of asbestos fibre

Ñ    Chrysolite (90%)

Ñ    Crocidolite (6%)

Ñ    Amosite (4%)

Crocidolite most likely to cause asbestosis and mesothelioma

Pathogenesis

Ñ    Long thin fibre, easily inhaled

Ñ    Rotation of fibre (turbulent airflow in expiration) causes impaction

Ñ    Fibres resistant to enzymatic degradation by macrophages and neutrophils

Lung injury and progressive fibrosis:

Probably caused by:

Ñ    Enzymes and free radicals released by neutrophils or macrophages

Ñ    Release of fibrogenic cytokines and growth factors by alveolar macrophages

Ñ    Direct stimulation of collagen synthesis by asbestos

Clinical Features

Ñ    Asbestos bodies:

No effects of clinical significance

Ñ    Pleural plaques:

Mild restrictive ventilatory defect

Ñ    Effusion:

Restrictive defect presents with pain and dyspnoea. May be recurrent

Ñ    Bilateral diffuse pleural thickening:

Restrictive defect, causes dyspnoea on effort, may progress

Ñ    Mesothelioma:

Restrictive defect, presents with pain and dyspnoea, usually fatal

Ñ    Asbestosis:

Severe restrictive defect with reduced gas transfer

Poor prognosis

Ñ    Asbestos related bronchial carcinoma:

Presents with features of asbestosis, pleural plaques or pleural thickening and features of bronchial carcinoma

Smoking increases risk fivefold

 

 

Asbestosis

Title                    

Ñ    Asbestosis

Definition

Ñ    Fibrosis of lungs caused by asbestos dust

Ñ    May or may not be associated with fibrosis of the visceral or parietal pleura

Clinical Features

History

Ñ    Presents 5-10 years after heavy exposure

RS

Ñ    Dyspnoea

Examination

IS

Ñ    Clubbing

RS

Ñ    Bilateral, end-inspiratory crepitations (crackles)

Investigations

Imaging

Chest X-ray

Ñ    Diffuse bilateral streaky shadows

Ñ    Honeycomb lung

Physiological studies

Ñ    Restrictive ventilatory defect

Ñ    Reduced gas transfer

Management

Control

Drugs

Ñ    No treatment alters progress

Ñ    Steroids may be tried

Prognosis

Ñ    Poor

 

 

Malignant Mesothelioma

Title               

Ñ    Malignant Mesothelioma

Definition

Ñ    Tumour derived from mesothelial cells

Ñ    Arises in pleura, pericardium or peritoneum

Pathogenesis

Histolopathology may show:

Ñ    Sarcomatoid conformation:

Malignant spindle shaped cells like fibrosarcoma

Ñ    Epithelioid form:

Epithelium like cells that form tubules and papillary projections that look like adenocarcinoma

Ñ    Tumour spreads over the surface of the lung and its fissures forming a sheath of tissue around it

Clinical Features

History

Age

Ñ    50-70 years

Sex

Ñ    Males > Females

E&M

Ñ    Tiredness

Ñ    Weight loss

Ñ    Fever

Ñ    Drenching sweats:

Sometimes

RS

Ñ    Pain

Ñ    Dyspnoea

GIT

Ñ    Anorexia

Social history

Ñ    Exposure to asbestos

Ñ    Lag 20-40 years

Examination

E&M

Ñ    Weight loss

IS

Ñ    Clubbing:

Rare

RS

Ñ    Pleural effusion

Ñ    Mass in chest wall:

Tumour extension

Investigations

Fluids

Pleural aspiration

Ñ    Cytology

Ñ    Risk of seeding of tumour cells along needle tract

Imaging

Chest X-ray

Ñ    Effusion

Surgery

Ñ    Thoracocoscopy or thoracotomy:

Rarely

Tissue Diagnosis

Ñ    Diversity of patterns from well differentiated epithelial or sarcomatous to undifferentiated

Management

Control

Drugs

Ñ    Cytotoxics tried, no convincing success

Surgery

Ñ    Tried for limited disease

Radiotherapy

Ñ    Palliative

Ñ    Radiotherapy to needle tract following pleural aspiration or biopsy:

Prevent seeding

Prognosis

Ñ    Poor

Ñ    Most dead within 2 years

 

 

Back ] Up ] Next ]

 

 

[Up]